ALBERTDAVD850.00

Albert David Limited

· Pharma & Health
₹ CrorePeersVALIANTLABHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹485 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation6.87.09.8
+ Finance Costs0.30.42.6
+ Interest Income-4.1-3.80.0
+ Dividend Income-0.4-0.20.1
+ Fair Value (Gains) / Losses-45.6-19.83.9
+ Unrealised FX (Gain) / Loss0.00.00.1
+ Other Non-cash Items0.0-0.3-0.0
+ Other Reconciling Items-1.50.9-0.6
Changes in Working Capital
+ Inventories7.1-20.35.6
+ Trade Receivables — Current1.01.9-6.6
+ Other Financial Assets — Current-0.40.00.0
+ Other Financial Assets — Non-current0.0-0.30.0
+ Other Current Assets-0.3-3.6-5.3
+ Other Non-current Assets0.01.80.4
+ Other Bank Balances0.0-0.00.0
+ Trade Payables — Current1.83.6-5.1
+ Other Financial Liabilities — Current-3.1-4.90.0
+ Other Financial Liabilities — Non-current-0.6-0.2-3.3
+ Other Current Liabilities2.3-2.7-0.8
+ Provisions — Current0.4-0.00.0
+ Provisions — Non-current0.5-4.80.0
Cash from Operating Activities
Profit Before Tax (per I/S)97.325.20.527.9
+ Total Adjustments (incl. Working Capital)-35.7-45.20.7
Cash from Operations (pre-tax)61.6-19.91.3
+ Interest Received — Operating0.00.0-3.7
+ Dividends Received — Operating0.00.00.1
+ Other Inflows / (Outflows) — Operating0.00.0-0.3
+ Income Taxes Paid16.18.55.0
Cash from Operating Activities45.5-28.4-7.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)10.914.90.0
+ Disp of Fixed Assets0.00.30.3
+ Disp of Intangible Assets0.00.00.4
+ Acq of Intangibles under Development0.00.029.1
+ Acq of Investment Property40.90.00.0
+ Disp of Investment Property0.031.013.9
+ Disp of Other Long-term Assets0.01.70.0
+ Sale of Investments (Equity / Debt)7.71.60.0
+ Loans & Advances Repaid5.00.02.0
+ Dividends Received — Investing0.40.20.1
+ Interest Received — Investing5.43.44.1
+ Other Inflows / (Outflows) — Investing0.00.04.0
Cash from Investing Activities-33.223.3-4.4
Cash from Financing Activities
+ Proceeds from Borrowings0.07.918.4
+ Repayment of Borrowings1.90.00.0
+ Payment of Lease Liabilities1.01.01.2
+ Interest Paid0.26.52.5
+ Dividends Paid5.20.22.9
Cash from Financing Activities-8.30.111.9
Net Changes in Cash (pre-FX)4.0-5.0-0.1
+ Effect of FX Rate Changes on Cash0.00.00.0
Net Changes in Cash4.0-5.0-0.1
Closing Cash5.4
Reference Items
EBITDA46.93.05.526.8
EBITDA Margin %12.930.881.647.34
Free Cash Flow (CFO − Capex)34.6-43.3-7.7-7.7
Free Cash Flow to Equity-41.98.3
Free Cash Flow per Basic Share60.67-75.85-13.42-13.42
Cash Flow to Net Income0.60-1.655.12
Cash Paid for Taxes16.18.55.0
Cash Paid for Interest0.26.52.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.